Compare First Trust NASDAQ 100 Technology Index Fund (QTEC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Trust NASDAQ 100 Technology Index Fund vs Zoetis Inc — how do they compare? First Trust NASDAQ 100 Technology Index Fund trades at $331.55 (market cap $4.10B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 7.4× First Trust NASDAQ 100 Technology Index Fund's market cap, and Zoetis Inc pays a 2.9% dividend while First Trust NASDAQ 100 Technology Index Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ 100 Technology Index Fund for 40 Days and Zoetis Inc for 70 Days on average.
| QTEC | ZTS | |
|---|---|---|
Market Cap | $4.10B | $30.20B |
Volume | 264,303 | 6,175,327 |
Sector | Broad Market / Factor | Health |
52-Week High | $340.28 | $147.53 |
52-Week Low | $207.03 | $69.09 |
Typical Hold Time | 40 Days | 70 Days |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $329.21, down 1.97% over the past 24 hours. Technical indicators show a bullish trend with strong moving average signals, while oscillators remain neutral. The ETF provides equal-weighted exposure to the technology sector, with recent analysis highlighting its broader sector definition and liquidity advantages over peers like RSPT. Key support and resistance levels are closely watched near current prices.
The outlook for QTEC is cautiously optimistic, driven by technology sector exposure and equal-weight diversification. Risks include sector volatility and macroeconomic pressures on tech stocks. Investment appeal hinges on sustained tech growth, but investors face typical market fluctuations inherent to sector-focused ETFs.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
